JPMorgan lowered the firm’s price target on Monster Beverage to $50 from $56 and keeps a Neutral rating on the shares post the Q2 report. The company reported its slowest sales growth quarter since Q2 of 2015 and biggest sales miss versus consensus since Q4 of 2015, the analyst tells investors in a research note. The firm finds it concerning is that the slowdown doesn’t appear confined to the U.S.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNST:
- MNST Earnings: Monster Beverage Drops on Q2 Earnings Miss
- Monster Beverage Reports 2024 Second Quarter Financial Results
- Monster Beverage put volume heavy and directionally bearish
- Monster Beverage to Report Financial Results for 2024 Second Quarter on August 7, 2024
- MNST Earnings Report this Week: Is It a Buy, Ahead of Earnings?